Table 1 Demographic data for each glioma biomarker
From: Multiparametric MR radiomics in brain glioma: models comparation to predict biomarker status
Total | Status | N (%) | Age (Q1, Q3) | Sex (M/F) | Enhancement (%) | WHO grade (I/II/III/IV) |
|---|---|---|---|---|---|---|
81 (100) | 40/41 | 61 (75) | 2/26/29/24 | |||
IDH | Â | Â | Â | Â | Â | Â |
| Â | Wild-type | 42 (52) | 57 (44, 64) | 21/21 | 38 (90) | 2/9/10/21 |
| Â | Mutant | 39 (48) | 44 (38, 51) | 19/20 | 22 (56) | 0/17/19/3 |
MGMT | Â | Â | Â | Â | Â | Â |
| Â | Nonmethylated | 31 (38) | 57 (42, 64) | 16/15 | 27 (87) | 2/9/8/12 |
| Â | Methylated | 50 (62) | 45 (39, 58) | 24/26 | 33 (66) | 0/17/21/12 |
TERT | Â | Â | Â | Â | Â | Â |
| Â | Wild-type | 34 (42) | 46 (37, 57) | 16/18 | 22 (65) | 2/15/10/7 |
| Â | Mutant | 47 (58) | 52 (43, 64) | 24/23 | 38 (81) | 0/11/19/17 |
1p/19q | Â | Â | Â | Â | Â | Â |
| Â | Wild-type | 52 (64) | 53 (39, 62) | 26/26 | 39 (75) | 2/17/15/18 |
| Â | codeletion | 29 (36) | 45 (42, 58) | 14/15 | 21 (72) | 0/9/14/6 |